GH Research IPO

GH Research Files to Go Public Only Two Months After Raising $125 Million

The psychedelics space continues to see rapid growth, as a relatively quiet company, GH Research, filed to go public on June 4, 2021. This comes only two months after raising a nine-figure, oversubscribed series B round from RA Capital, RTW Investments, BVF Partners.  The Dublin-based biotech is focused on developing a novel and proprietary inhalable […]


Defiance ETFs Launches $PSY, the First U.S.-listed ETF Focused on Psychedelics

Yesterday, Psychedelic Invest published a post highlighting Defiance ETFs new psychedelic ETF and what it’s potential holdings may be. Today, we find out exactly what it contains as the fund is officially available to trade on the NYSE under the symbol $PSY. About Defiance: Founded in 2018, Defiance is a FinTech asset manager and an […]

defiance PSY ETF

A Second Psychedelics ETF Prepares To Trade… Here are the Top 10 Holdings

ETF provider, Defiance, continues to prepare for the launch of it’s Next Gen Altered Experience ETF under the symbol PSY.  As previously reported by Psychedelic Invest, Defiance aims to take advantage of the burgeoning psychedelics market by becoming the second ETF to focus on the market.  The first psychedelics ETF, provided by Horizons ETF has […]

Psychedelic Invest Adds 12 New Companies

We’re excited to welcome 12 new companies to the Psychedelic Invest Index – the first and most comprehensive index covering the entire publicly traded psychedelics market. In total, the index now comprises 51 constituents. The latest additions include:  Creso Pharma Limited Ticker(s): ASX:CPH, OTC:COPHF IPO Date: October 2016 Focus/ Sector: Psilocybin, LSD, MDMA, Cannabis Investor […]